skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 38  for All Library Resources

Results 1 2 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA)
Material Type:
Article
Add to My Research

Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA)

Vaccines (Basel), 2023-04, Vol.11 (4), p.852 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11040852 ;PMID: 37112764

Full text available

2
Immunogenicity and Safety of Anti-SARS-CoV-2 mRNA Vaccines in a Cohort of Patients with Hereditary Angioedema
Material Type:
Article
Add to My Research

Immunogenicity and Safety of Anti-SARS-CoV-2 mRNA Vaccines in a Cohort of Patients with Hereditary Angioedema

Vaccines (Basel), 2023-01, Vol.11 (2), p.215 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11020215 ;PMID: 36851094

Full text available

3
Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective
Material Type:
Article
Add to My Research

Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective

Vaccines (Basel), 2022-02, Vol.10 (2), p.342 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10020342 ;PMID: 35214800

Full text available

4
Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines—A Case Series
Material Type:
Article
Add to My Research

Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines—A Case Series

Vaccines (Basel), 2021-11, Vol.9 (11), p.1349 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111349 ;PMID: 34835280

Full text available

5
Ocular Manifestations after Receiving COVID-19 Vaccine: A Systematic Review
Material Type:
Article
Add to My Research

Ocular Manifestations after Receiving COVID-19 Vaccine: A Systematic Review

Vaccines (Basel), 2021-11, Vol.9 (12), p.1404 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9121404 ;PMID: 34960150

Full text available

6
Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
Material Type:
Article
Add to My Research

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination

Vaccines (Basel), 2021-09, Vol.9 (9), p.974 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9090974 ;PMID: 34579211

Full text available

7
COVID-19 Vaccine-Associated Optic Neuropathy: A Systematic Review of 45 Patients
Material Type:
Article
Add to My Research

COVID-19 Vaccine-Associated Optic Neuropathy: A Systematic Review of 45 Patients

Vaccines (Basel), 2022-10, Vol.10 (10), p.1758 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10101758 ;PMID: 36298623

Full text available

8
Sweet Syndrome Following SARS-CoV2 Vaccination
Material Type:
Article
Add to My Research

Sweet Syndrome Following SARS-CoV2 Vaccination

Vaccines (Basel), 2021-11, Vol.9 (11), p.1212 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111212 ;PMID: 34835143

Full text available

9
A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine
Material Type:
Article
Add to My Research

A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine

Vaccines (Basel), 2021-09, Vol.9 (10), p.1108 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9101108 ;PMID: 34696214

Full text available

10
Severe Acute Myocarditis after the Third (Booster) Dose of mRNA COVID-19 Vaccination
Material Type:
Article
Add to My Research

Severe Acute Myocarditis after the Third (Booster) Dose of mRNA COVID-19 Vaccination

Vaccines (Basel), 2022-04, Vol.10 (4), p.575 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10040575 ;PMID: 35455324

Full text available

11
Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns
Material Type:
Article
Add to My Research

Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns

Vaccines (Basel), 2021-11, Vol.9 (11), p.1274 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111274 ;PMID: 34835205

Full text available

12
Anthrax Vaccines in the 21st Century
Material Type:
Article
Add to My Research

Anthrax Vaccines in the 21st Century

Vaccines (Basel), 2024-02, Vol.12 (2), p.159 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 by the authors. 2024 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12020159 ;PMID: 38400142

Full text available

13
New-Onset Acute Kidney Disease Post COVID-19 Vaccination
Material Type:
Article
Add to My Research

New-Onset Acute Kidney Disease Post COVID-19 Vaccination

Vaccines (Basel), 2022-05, Vol.10 (5), p.742 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10050742 ;PMID: 35632497

Full text available

14
Death from COVID-19 in a Fully Vaccinated Subject: A Complete Autopsy Report
Material Type:
Article
Add to My Research

Death from COVID-19 in a Fully Vaccinated Subject: A Complete Autopsy Report

Vaccines (Basel), 2023-01, Vol.11 (1), p.142 [Peer Reviewed Journal]

2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11010142 ;PMID: 36679987

Full text available

15
Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA Vaccines
Material Type:
Article
Add to My Research

Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA Vaccines

Vaccines (Basel), 2023-02, Vol.11 (2), p.417 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11020417 ;PMID: 36851293

Full text available

16
Herpetic Keratitis Preceded by COVID-19 Vaccination
Material Type:
Article
Add to My Research

Herpetic Keratitis Preceded by COVID-19 Vaccination

Vaccines (Basel), 2021-11, Vol.9 (12), p.1394 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9121394 ;PMID: 34960139

Full text available

17
Parsonage-Turner Syndrome following COVID-19 Vaccination: A Systematic Review
Material Type:
Article
Add to My Research

Parsonage-Turner Syndrome following COVID-19 Vaccination: A Systematic Review

Vaccines (Basel), 2024-03, Vol.12 (3), p.306 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 by the authors. 2024 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12030306 ;PMID: 38543940

Full text available

18
Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult
Material Type:
Article
Add to My Research

Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult

Vaccines (Basel), 2022-01, Vol.10 (1), p.87 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10010087 ;PMID: 35062748

Full text available

19
Right Biceps Pseudo-Tumor from COVID-19 Vaccination
Material Type:
Article
Add to My Research

Right Biceps Pseudo-Tumor from COVID-19 Vaccination

Vaccines (Basel), 2024-02, Vol.12 (2), p.160 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 by the authors. 2024 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12020160 ;PMID: 38400143

Full text available

20
COVID Vaccine-Associated Myocarditis in Adolescent Siblings: Does It Run in the Family?
Material Type:
Article
Add to My Research

COVID Vaccine-Associated Myocarditis in Adolescent Siblings: Does It Run in the Family?

Vaccines (Basel), 2022-04, Vol.10 (4), p.611 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10040611 ;PMID: 35455360

Full text available

Results 1 - 20 of 38  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2020  (1)
  2. 2020 To 2020  (1)
  3. 2021 To 2021  (7)
  4. 2022 To 2023  (25)
  5. After 2023  (5)
  6. More options open sub menu

Searching Remote Databases, Please Wait